DERMOVATE 0.5mg/ml 0.05% skin solution medication leaflet

D07AD01 clobetasol • Dermatologicals | Corticosteroids, plain | Corticosteroids, very potent (group iv)

Clobetasol is a very potent corticosteroid used for the treatment of inflammatory and pruritic skin conditions such as psoriasis, atopic dermatitis, and lichen planus. It works by reducing inflammation, itching, and redness of the skin.

The medication is applied topically, as directed by a doctor, usually once or twice daily to the affected areas. It is important for patients not to exceed the recommended treatment duration to avoid adverse effects.

Patients should be aware of potential side effects, such as skin thinning, local irritation, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include skin thinning, local irritation, and dryness. In rare cases, severe reactions such as hypothalamic-pituitary-adrenal axis suppression or severe allergic reactions may occur. Patients should be informed of these risks before use.

General data about DERMOVATE 0.5mg/ml 0.05%

Substance: clobetasol

Date of last drug list: 01-12-2018

Commercial code: W64943002

Concentration: 0.05%

Pharmaceutical form: skin solution

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ASPEN BAD OLDESLOE GMBH - GERMANIA

Holder: GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA

Number: 11259/2018/02

Shelf life: 2 years - after packing for marketing; after the first opening a pungii - 12 weeks

Pharmaceutical forms available for clobetasol

Concentrations available for clobetasol

0.05%, 0.5mg/g, 0.5mg/ml, 500mcg/g